Calumet Specialty Products Partners - CLMT Stock Forecast, Price & News

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Calumet Specialty Products Partners in the last year. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" CLMT shares.
View CLMT analyst ratings or view top-rated stocks.

6 brokerages have issued 12 month target prices for Calumet Specialty Products Partners' stock. Their CLMT share price forecasts range from $20.00 to $30.00. On average, they expect the company's stock price to reach $25.50 in the next year. This suggests a possible upside of 76.6% from the stock's current price.
View analysts price targets for CLMT or view top-rated stocks among Wall Street analysts.

Calumet Specialty Products Partners' stock was trading at $13.20 on January 1st, 2022. Since then, CLMT shares have increased by 9.4% and is now trading at $14.44.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Friday, November 4th 2022.
View our CLMT earnings forecast.

Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) issued its quarterly earnings data on Friday, November, 5th. The oil and gas company reported $0.64 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.15) by $0.79. The oil and gas company earned $874.90 million during the quarter, compared to analyst estimates of $864 million. During the same quarter in the previous year, the business posted ($0.49) earnings per share.

18 employees have rated Calumet Specialty Products Partners Chief Executive Officer Tim Go on Glassdoor.com. Tim Go has an approval rating of 42% among the company's employees. This puts Tim Go in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Calumet Specialty Products Partners investors own include Chembio Diagnostics (CEMI), Prospect Capital (PSEC), Two Harbors Investment (TWO), BlackRock Capital Investment (BKCC), NovoCure (NVCR), Summit Midstream Partners (SMLP), Viper Energy Partners (VNOM), Washington Prime Group (WPG), Roper Technologies (ROP) and New Residential Investment (NRZ).

Calumet Specialty Products Partners trades on the NASDAQ under the ticker symbol "CLMT."

Calumet Specialty Products Partners' stock is owned by many different institutional and retail investors. Top institutional shareholders include Adams Asset Advisors LLC (6.86%), Knott David M Jr (5.46%), FMR LLC (1.09%), Goldman Sachs Group Inc. (0.40%), Barnett & Company Inc. (0.38%) and LPL Financial LLC (0.18%). Insiders that own company stock include H Keith Jennings, Louis Todd Borgmann, Ryan Willman, Scott Obermeier and Stephen P Mawer.
View institutional ownership trends.

Shares of CLMT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CLMT stock can currently be purchased for approximately $14.44.

Calumet Specialty Products Partners (NASDAQ:CLMT) has a market capitalization of $1.14 billion and generates $3.15 billion in revenue each year. The oil and gas company earns $-260,100,000.00 in net income (profit) each year or ($1.81) on an earnings per share basis.

The company employs 1,450 workers across the globe.

Calumet Specialty Products Partners' mailing address is 2780 WATERFRONT PARKWAY EAST DRIVE SUITE 200, INDIANAPOLIS IN, 46214. The official website for the company is www.calumetspecialty.com. The oil and gas company can be reached via phone at (317) 328-5660, via email at investorrelations@clmt.com, or via fax at 317-328-2359.